Collectively, these findings advance our understanding of how impaired mitochondrial dynamics and quality control may contribute to skeletal muscle insulin resistance and the manifestation of T2D and provides key evidence that DUB antagonists may play an important role in preventing or treating T2D. Here, ZUP1 is linked to type 2 diabetes mellitus.